OKYO PHARMA LTD Aktie - Unternehmensdaten & Kurse - GG00BD3FV870 | goSPATZ

OKYO PHARMA LTD

Action · GG00BD3FV870 · A2JQ3D (XLON)

Aperçu Indicateurs financiers

Pas de cours

n/a

Performance

Heute	Woche	Monat	3 Monate	6 Monate	1 Jahr	5 Jahre
-	-	-	-	-4,11 %	-2,75 %	-72,45 %

Firmenprofil zu OKYO PHARMA LTD Aktie

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

Unternehmensdaten

Name OKYO PHARMA LTD

Firma OKYO Pharma Limited

Website https://www.okyopharma.com

Heimatbörse

London

WKN A2JQ3D

ISIN GG00BD3FV870

Wertpapierart Aktie

Sektor Healthcare

Branche Biotechnology

CEO Dr. Gary S. Jacob Ph.D.

Marktkapitalisierung 23 Mio

Land Großbritannien und Nordirland

Währung EUR

Mitarbeiter 0,0 T

Adresse 55 Park Lane, W1K 1NA London

IPO Datum 2018-07-17

Ticker Symbols

Name	Symbol
London	OKYO.L

More Shares

Investors who OKYO PHARMA LTD hold also have the following shares in their portfolio:

NATL AUSTR. BK 15/27 MTN Bond

PEPSICO 20/27 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025